Last Updated: June 18, 2026

Drug Price Trends for NDC 00955-2900

✉ Email this page to a colleague

« Back to Dashboard

Average Pharmacy Cost for 00955-2900

Subscribe to access the full database, or Start Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
INSULIN GLARGINE MAX SOLO U300	00955-2900-02	26.98949	ML	2026-06-17
INSULIN GLARGINE MAX SOLO U300	00955-2900-02	26.97957	ML	2026-05-20
INSULIN GLARGINE MAX SOLO U300	00955-2900-02	26.95954	ML	2026-04-22
INSULIN GLARGINE MAX SOLO U300	00955-2900-02	36.63224	ML	2025-12-17
INSULIN GLARGINE MAX SOLO U300	00955-2900-02	36.68193	ML	2025-11-19
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Best Wholesale Price for NDC 00955-2900

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
INSULIN,GLARGINE,HUMAN (TOUJEO MAX) 300 UNIT/	Sanofi Aventis U.S. LLC	00955-2900-02	2X3ML	174.58		2023-04-26 - 2028-05-31	Big4
INSULIN,GLARGINE,HUMAN (TOUJEO MAX) 300 UNIT/	Sanofi Aventis U.S. LLC	00955-2900-02	2X3ML	227.42		2023-04-26 - 2028-05-31	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.